News
All News
Publications
All PublicationsPharmTechPharmTech Europe
Multimedia
All VideosAsk the ExpertBehind The HeadlinesDrug Digest VideosDrug Solutions Podcast
Conferences
Conference CoverageConference Listing
More
Webcasts
Resources
ICH Q9 Revision: A Comprehensive Resource on Quality Risk ManagementPeer-Reviewed ResearchPharmTech ProductsPharma InsightsSponsored PodcastsSponsored VideosSponsored eBooksWhitepapers

Subscribe

  • News
  • Publications
  • Multimedia
  • Conferences
  • Webcasts
  • Resources
  • Subscribe
  • Analytics
    • Bio/Pharmaceutical Analysis Techniques
    • Laboratory Equipment and Instruments
  • Data and Artificial Intelligence
  • Dosage Forms
    • Solid/Semi-Solid Dosage
    • Specialty Dosage Drugs
    • Parenterals and Injectables
    • Inhalation Drugs
  • Drug Development
    • Intellectual Property and Patents
    • Process and Scaling
    • APIs and Excipients
    • Ingredients
    • Formulation and Drug Delivery
  • Manufacturing
    • Aseptic/Sterile Processing
    • Equipment
    • Process and Automation
    • Manufacturing, Parenterals and Injectables
    • Manufacturing, Biosimilars and Biobetters
    • Manufacturing, Inhalation Drugs
    • Manufacturing, Solid and Semi-Solid Dosage Drugs
    • Manufacturing, Cell Therapies
    • Manufacturing, Biologic Drugs
    • Supply Chain
    • Manufacturing, Gene Therapies
    • Packaging and Distribution
  • Outsourcing
    • Contract Research Services
    • Contract Analytical Services
    • Contract Development Services
    • Regulatory Consulting
    • Logistics and Distribution
    • Contract Manufacturing Services
  • Quality Systems
    • Ask the Expert
    • Quality Assurance/Quality Control
    • Regulatory Oversight and Compliance
Spotlight -
Analytics|
Dosage Forms|
Drug Development|
Manufacturing|
Outsourcing|
Quality Systems
Advertisement

Anita Szajek

Advertisement

Anita Szajek is principal scientific liaison at the US Pharmacopeia.

Articles by Anita Szajek

Diversifying the Global Heparin Supply Chain: Reintroduction of Bovine Heparin in the United States?

ByAnita Szajek,Elaine Gray,David Keire,Barbara Mulloy,Ali Al-Hakim,Christina Chase,Monica Da Luz Carvalho Soares,Damian Cairatti,John Hogwood,Paulo Mourão,Tina S. Morris, PhD
November 2nd 2015

The global supply chain for bovine and porcine heparin and regulatory considerations are examined.

Control Strategies for Synthetic Therapeutic Peptide APIs Part II: Raw Material Considerations

ByAleksander Swietlow,Michael Verlander,Brian Gregg,Harold Rode,Ivo Eggen,Anita Szajek,Anita Y. Szajek
April 2nd 2014

USP evaluates raw materials used in the chemical synthesis of peptides.

Control Strategies for Synthetic Therapeutic Peptide APIs—Part I: Analytical Consideration

ByAleksander Swietlow,Michael Verlander,Brian Gregg,Harold Rode,Ivo Eggen,Anita Szajek
March 2nd 2014

USP evaluates quality attributes for synthetic peptides.

Advertisement

Latest Updated Articles

  • Control Strategies for Synthetic Therapeutic Peptide APIs Part II: Raw Material Considerations
    Control Strategies for Synthetic Therapeutic Peptide APIs Part II: Raw Material Considerations

    Published: April 2nd 2014 | Updated:

  • Control Strategies for Synthetic Therapeutic Peptide APIs—Part I: Analytical Consideration
    Control Strategies for Synthetic Therapeutic Peptide APIs—Part I: Analytical Consideration

    Published: March 2nd 2014 | Updated:

  • Diversifying the Global Heparin Supply Chain: Reintroduction of  Bovine Heparin in the United States?
    Diversifying the Global Heparin Supply Chain: Reintroduction of Bovine Heparin in the United States?

    Published: November 2nd 2015 | Updated:



Advertisement
Advertisement

Trending on Pharmaceutical Technology

1

Integrating Sustainability into the Core of Pharmaceutical Science

2

Outsourcing Partners Providing End-to-End Service

3

Kimberly-Clark to Buy Tylenol Maker Kenvue: Analyzing Risks and Rewards

  • About Us
  • Advertise
  • Contact Us
  • Editorial Info
  • Editorial Advisory Board
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us